tiprankstipranks
Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
PremiumPress ReleasesPurple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
2d ago
Purple Biotech Reveals Encouraging Cancer Study Results
PremiumCompany Announcements
Purple Biotech Reveals Encouraging Cancer Study Results
6d ago
Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit
PremiumPress Releases
Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit
6d ago
Promising Pancreatic Cancer Therapy from Purple Biotech
PremiumCompany AnnouncementsPromising Pancreatic Cancer Therapy from Purple Biotech
30d ago
Purple Biotech announces late-breaking interim randomized Phase 2 data
PremiumThe Fly
Purple Biotech announces late-breaking interim randomized Phase 2 data
1M ago
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
PremiumPress Releases
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
1M ago
Purple Biotech’s Phase 2 pancreatic cancer study selected as presentation
PremiumThe FlyPurple Biotech’s Phase 2 pancreatic cancer study selected as presentation
2M ago
Purple Biotech’s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
PremiumPress Releases
Purple Biotech’s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
2M ago
Purple Biotech’s NT219 Shows Promising Cancer Fight
PremiumCompany Announcements
Purple Biotech’s NT219 Shows Promising Cancer Fight
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100